Carlos A.M. Fraga and Eliezer J. Barreiro Pages 167 - 198 ( 32 )
In this article we provide an overview on the medicinal chemistry of new bioactive N-acylhydrazone (NAH) derivatives designed through the structural optimization of N-arylhydrazone precursors, originally planned by molecular hybridization of two known 5-lipoxygenase inhibitors, i.e. CBS-1108 and BW-755c. The analgesic, antiedematogenic and platelet anti-aggregating profile of several isosteric NAH compounds was investigated by using classical in vivo and ex-vivo pharmacological assays, which allowed the identification of new potent centrally and peripherically-acting analgesic leads, new antiinflammatory agents and new antithrombotic prototypes. During this study, dozens of active NAH compounds were discovered, clarifying the structure-activity relationships for this series of derivatives and indicating the pharmacophoric character of the N-acylhydrazone moiety for its biological profile.
Bioactive N-acylhydrazone derivatives,antiinflammatory,analgesic and antithrombotic properties,molecular hybridization and bioisosterism in drug design
, Laboratorio de Avaliacao eSÃntese de Substancias Bioativas (LASSBio), Faculdade de Farmacia,Universidade Federal do Rio de Janeiro, PO Box 68006, ZIP CODE21944-971, Rio de Janeiro, RJ, Brazil.